American Society of Addiciton Medicine
Sep 14, 2018 Reporting from Rockville, MD
ASAM and NJSAM Submit Letters of Support for Legislation Requiring State Insurers to Cover Buprenorphine Costs and Prohibit Utilization Controls
https://www.asam.org/news/detail/2018/09/14/asam-and-njsam-submit-letters-of-support-for-legislation-requiring-state-insurers-to-cover-buprenorphine-costs-and-prohibit-utilization-controls
Sep 14, 2018
ASAM and the New Jersey Society of Addiction Medicine (NJSAM) submitted letters of support with recommended revision for A4138 and S1051, legislation that would require state insurance providers to cover the costs of buprenorphine and prohibit utilization controls.

ASAM and NJSAM Submit Letters of Support for Legislation Requiring State Insurers to Cover Buprenorphine Costs and Prohibit Utilization Controls.Substring(0, maxlength)

American Society of Addictin Medicine

News

ASAM and NJSAM Submit Letters of Support for Legislation Requiring State Insurers to Cover Buprenorphine Costs and Prohibit Utilization Controls

Sep 14, 2018

Letter of Support for A4138

Letter of Support for S1051

 

ASAM and the New Jersey Society of Addiction Medicine (NJSAM) submitted letters of support with recommended revision for A4138 and S1051, legislation that would require state insurance providers to cover the costs of buprenorphine and prohibit utilization controls.